Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Fumihiko, Matsuzawa"'
Autor:
Fumihiko Matsuzawa, Hirofumi Kamachi, Tatsuzo Mizukami, Takahiro Einama, Futoshi Kawamata, Yuki Fujii, Moto Fukai, Nozomi Kobayashi, Yutaka Hatanaka, Akinobu Taketomi
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-16 (2021)
Abstract Background Mesothelin is a 40-kDa glycoprotein that is highly overexpressed in various types of cancers, however molecular mechanism of mesothelin has not been well-known. Amatuximab is a chimeric monoclonal IgG1/k antibody targeting mesothe
Externí odkaz:
https://doaj.org/article/59a5ff8880764bcdb8c4c420ec5d8690
Autor:
Hirotaka Watanabe, Kojiro Ishibashi, Hiroki Mano, Sho Kitamoto, Nanami Sato, Kazuya Hoshiba, Mugihiko Kato, Fumihiko Matsuzawa, Yasuto Takeuchi, Takanobu Shirai, Susumu Ishikawa, Yuka Morioka, Toshiaki Imagawa, Kazuyasu Sakaguchi, Suguru Yonezawa, Shunsuke Kon, Yasuyuki Fujita
Publikováno v:
Cell Reports, Vol 23, Iss 13, Pp 3721-3729 (2018)
Summary: p53 is a tumor suppressor protein, and its missense mutations are frequently found in human cancers. During the multi-step progression of cancer, p53 mutations generally accumulate at the mid or late stage, but not in the early stage, and th
Externí odkaz:
https://doaj.org/article/7b3d5f86dea4489d8d609ac4b73d0b9d
Autor:
Sunao Fujiyoshi, Tatsuhiko Kakisaka, Fumihiko Matsuzawa, Tatsushi Shimokuni, Shuhei Kii, Yuki Kuratani, Makoto Nishikawa, Ryo Morita, Katsuya Nakanishi, Tomofumi Takagi, Masahiro Takahashi
Publikováno v:
The Japanese Journal of Gastroenterological Surgery. 55:389-398
Autor:
Moto Fukai, Yuki Fujii, Fumihiko Matsuzawa, Hirofumi Kamachi, Akinobu Taketomi, Tatsuzo Mizukami, Nozomi Kobayashi
Publikováno v:
Investigational New Drugs. 39:1256-1266
Amatuximab is a promising therapeutic antibody targeting mesothelin, a 40-kDa glycoprotein that is highly expressed in pancreatic cancer. We investigated the effectiveness of early amatuximab treatment, imitating an adjuvant chemotherapy setting, and
Autor:
Tatsushi, Shimokuni, Sunao, Fujiyoshi, Fumihiko, Matsuzawa, Makoto, Nishikawa, Masahiro, Takahashi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 49(3)
In cancer treatment of the elderly, it is important to grasp the"degree of inflammation"and"nutritional status"in advance.This study aims to investigate the usefulness of preoperative modified Glasgow Prognostic score(mGPS)evaluation in elderly patie
Autor:
Takahiro Einama, Futoshi Kawamata, Hirofumi Kamachi, Hiroshi Nishihara, Shigenori Homma, Fumihiko Matsuzawa, Tatsuzo Mizukami, Yuji Konishi, Toshiya Kamiyama, Junji Yamamoto, Akinobu Taketomi, Satoru Todo
Publikováno v:
EBioMedicine, Vol 24, Iss C, Pp 16-17 (2017)
Externí odkaz:
https://doaj.org/article/4913d29e26ac40ac9512c6465ee2b170
Autor:
Akinobu Taketomi, Yutaka Hatanaka, Takahiro Einama, Fumihiko Matsuzawa, Moto Fukai, Tatsuzo Mizukami, Hirofumi Kamachi, Futoshi Kawamata, Nozomi Kobayashi, Yuki Fujii
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-16 (2021)
BMC Cancer
BMC Cancer
Background Mesothelin is a 40-kDa glycoprotein that is highly overexpressed in various types of cancers, however molecular mechanism of mesothelin has not been well-known. Amatuximab is a chimeric monoclonal IgG1/k antibody targeting mesothelin. We r
Autor:
Tatsuzo Mizukami, Nozomi Kobayashi, Yuki Fujii, Fumihiko Matsuzawa, Futoshi Kawamata, Hirofumi Kamachi, Takahiro Einama, Akinobu Taketomi, Yutaka Hatanaka
Publikováno v:
Oncotarget
Pancreatic cancer often has a very poor prognosis, even after complete resection. The recurrence of hepatic and peritoneal metastases is an important prognostic factor; therefore, the development of improved adjuvant therapy is urgently required. Mes
Autor:
Fumihiko Matsuzawa, Yuka Morioka, Mugihiko Kato, Kazuya Hoshiba, Kojiro Ishibashi, Toshiaki Imagawa, Takanobu Shirai, Sho Kitamoto, Shunsuke Kon, Yasuyuki Fujita, Nanami Sato, Kazuyasu Sakaguchi, Susumu Ishikawa, Yasuto Takeuchi, Suguru Yonezawa, Hirotaka Watanabe, Hiroki Mano
Publikováno v:
Cell Reports, Vol 23, Iss 13, Pp 3721-3729 (2018)
Summary: p53 is a tumor suppressor protein, and its missense mutations are frequently found in human cancers. During the multi-step progression of cancer, p53 mutations generally accumulate at the mid or late stage, but not in the early stage, and th
Autor:
Akinobu Taketomi, Shigenori Homma, Fumihiko Matsuzawa, Takahisa Ishikawa, Susumu Shibasaki, Hiroaki Iijima, Tadashi Yoshida, Norihiko Takahashi, Yuji Konishi, Hideki Kawamura
Publikováno v:
Surgical innovation. 24(6):590-597
Background. Although several types of staplers have been developed, staple-line leaks have been a great problem in gastrointestinal surgery. Powered linear staplers were recently developed to further reduce the risk of tissue trauma during laparoscop